ATE450270T1 - Impstoff gegen mikrobielle pathogenen - Google Patents

Impstoff gegen mikrobielle pathogenen

Info

Publication number
ATE450270T1
ATE450270T1 AT01963230T AT01963230T ATE450270T1 AT E450270 T1 ATE450270 T1 AT E450270T1 AT 01963230 T AT01963230 T AT 01963230T AT 01963230 T AT01963230 T AT 01963230T AT E450270 T1 ATE450270 T1 AT E450270T1
Authority
AT
Austria
Prior art keywords
heat shock
vaccine
present
shock protein
repressor
Prior art date
Application number
AT01963230T
Other languages
English (en)
Inventor
Camilo Colaco
Original Assignee
Immunobiology Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immunobiology Ltd filed Critical Immunobiology Ltd
Application granted granted Critical
Publication of ATE450270T1 publication Critical patent/ATE450270T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6043—Heat shock proteins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT01963230T 2000-09-04 2001-09-04 Impstoff gegen mikrobielle pathogenen ATE450270T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0021757.0A GB0021757D0 (en) 2000-09-04 2000-09-04 Vaccine against microbial pathogens
PCT/GB2001/003964 WO2002020045A2 (en) 2000-09-04 2001-09-04 Vaccine against microbial pathogens

Publications (1)

Publication Number Publication Date
ATE450270T1 true ATE450270T1 (de) 2009-12-15

Family

ID=9898866

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01963230T ATE450270T1 (de) 2000-09-04 2001-09-04 Impstoff gegen mikrobielle pathogenen

Country Status (15)

Country Link
US (1) US20050232946A1 (de)
EP (1) EP1315518B1 (de)
JP (1) JP2004508339A (de)
CN (1) CN1452495A (de)
AT (1) ATE450270T1 (de)
AU (1) AU2001284261A1 (de)
CA (1) CA2421229A1 (de)
DE (1) DE60140681D1 (de)
DK (1) DK1315518T3 (de)
ES (1) ES2337653T3 (de)
GB (1) GB0021757D0 (de)
IL (1) IL154727A0 (de)
PT (1) PT1315518E (de)
WO (1) WO2002020045A2 (de)
ZA (1) ZA200301759B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033446A1 (en) * 2004-09-21 2006-03-30 Astellas Pharma Inc. Aminoalcohol derivatives
DK2066341T3 (en) 2006-09-01 2015-10-19 Csl Ltd PROCEDURE FOR INITIATING OR INDUCING AN IMMUNE RESPONSE
WO2009021291A1 (en) * 2007-08-16 2009-02-19 The University Of Sydney Mycobacterium vaccine formulation
NZ583377A (en) 2007-10-12 2013-11-29 Csl Ltd Method of eliciting an immune response against pandemic influenza virus
GB0910591D0 (en) 2009-06-19 2009-07-29 Immunobiology Ltd Method for the purification of protein complexes
GB0916557D0 (en) 2009-09-21 2009-10-28 Health Prot Agency Commensal neisserial stress protein complexes
GB201104897D0 (en) 2011-03-23 2011-05-04 Immunobiology Ltd Method for the production of protein complexes and vaccine compositions comprising the same
WO2012145491A2 (en) * 2011-04-20 2012-10-26 Jason Fisher Composition and method for enhancing an immune response

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2054679T3 (es) * 1986-08-18 1994-08-16 British Tech Group Vacunas.
US5776724A (en) * 1988-10-24 1998-07-07 Yale University Chaperonin-mediated protein folding
JPH03204820A (ja) * 1989-10-12 1991-09-06 Nippon Saibai Suisan Kk エビ類の細菌性疾病予防ワクチン及びその製造法
US5843460A (en) * 1993-05-19 1998-12-01 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions, and nucleic acid sequences encoding said polypeptides
WO1995014093A1 (en) * 1993-05-19 1995-05-26 Institut Pasteur Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides
JPH0748398A (ja) * 1993-08-03 1995-02-21 Nippon Oil Co Ltd 変性蛋白質の再生方法及び変性蛋白質再生剤
US6420127B1 (en) * 1994-11-18 2002-07-16 Washington University Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections
US6872542B1 (en) * 1993-11-18 2005-03-29 Siga Pharmaceuticals, Inc. Treatment or prophylaxis of diseases caused by pilus-forming bacteria
US5961979A (en) * 1994-03-16 1999-10-05 Mount Sinai School Of Medicine Of The City University Of New York Stress protein-peptide complexes as prophylactic and therapeutic vaccines against intracellular pathogens
JPH11507214A (ja) * 1995-06-07 1999-06-29 バイオケム ヴァシーンズ インク． Ｈｓｐ７０ファミリーに属する連鎖球菌の熱ショック蛋白質メンバー
US5935576A (en) * 1995-09-13 1999-08-10 Fordham University Compositions and methods for the treatment and prevention of neoplastic diseases using heat shock proteins complexed with exogenous antigens
US7022328B1 (en) * 1995-11-30 2006-04-04 Australian Pork Limited Therapeutic and diagnostic compositions
US5747332A (en) * 1996-09-20 1998-05-05 University Of New Mexico Methods for purifying and synthesizing heat shock protein complexes
EP0950061A4 (de) * 1996-09-20 2000-04-12 Univ New Mexico Hitzeschockproteinkomplexe
US6331388B1 (en) * 1997-10-17 2001-12-18 Wisconsin Alumni Research Foundation Immune response enhancer
US5948646A (en) * 1997-12-11 1999-09-07 Fordham University Methods for preparation of vaccines against cancer comprising heat shock protein-peptide complexes
US6500434B1 (en) * 1998-04-23 2002-12-31 Medimmune, Inc. Chaperone and adhesin proteins; vaccines, diagnostics and method for treating infections
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
NZ509127A (en) * 1998-06-19 2004-01-30 Merieux Oravax Use of LT (E. coli) and CT (cholera toxin) for inducing immune responses against helicobacter infection
GB9818133D0 (en) * 1998-08-19 1998-10-14 Quadrant Holdings Cambridge Vaccine
AU3702800A (en) * 1999-02-22 2000-09-14 University Of British Columbia, The Caulobacter lps immunoadjuvant
US7041465B1 (en) * 1999-08-11 2006-05-09 Washington University Anti-bacterial compounds directed against pilus biogenesis, adhesion and activity; co-crystals of pilus subunits and methods of use thereof
GB9919734D0 (en) * 1999-08-19 1999-10-20 Colaco Camilo Vaccines from infectious agents
US6677139B1 (en) * 1999-12-23 2004-01-13 Genecor International, Inc. Methods for production of proteins in host cells
GB0004547D0 (en) * 2000-02-23 2000-04-19 Immunobiology Ltd Screening method for novel vaccine candidates and compositions obtained thereby
HUP0302681A3 (en) * 2000-04-17 2006-11-28 Hoe Mee Irvington Javelinization of protein antigens to heat shock proteins
CN1107681C (zh) * 2000-08-11 2003-05-07 中国科学院微生物研究所 乙肝病毒抗原多肽与热休克蛋白的复合物及其应用
US6932985B2 (en) * 2000-10-10 2005-08-23 Auburn University Azide method and composition for controlling deleterious organisms
WO2002059156A2 (en) * 2000-12-22 2002-08-01 Medimmune, Inc. Therapeutic compounds structurally-linked to bacterial polypeptides
US20030216315A1 (en) * 2002-02-13 2003-11-20 Duke University Modulation of immune response by non-peptide binding stress response polypeptides
US8088569B2 (en) * 2002-03-01 2012-01-03 Applied Immune Technologies Immunogens for treatment of neoplastic and infectious disease
US20040022796A1 (en) * 2002-05-02 2004-02-05 University Of Connecticut Health Center Using heat shock proteins and alpha-2-macroglobulins to increase the immune response to vaccines comprising heat shock protein-peptide complexes or alpha-2-macroglobulin-peptide complexes

Also Published As

Publication number Publication date
CA2421229A1 (en) 2002-03-14
WO2002020045A3 (en) 2002-10-31
DK1315518T3 (da) 2010-04-19
ES2337653T3 (es) 2010-04-28
CN1452495A (zh) 2003-10-29
AU2001284261A1 (en) 2002-03-22
EP1315518B1 (de) 2009-12-02
DE60140681D1 (de) 2010-01-14
EP1315518A2 (de) 2003-06-04
ZA200301759B (en) 2004-06-22
WO2002020045A2 (en) 2002-03-14
JP2004508339A (ja) 2004-03-18
US20050232946A1 (en) 2005-10-20
IL154727A0 (en) 2003-10-31
GB0021757D0 (en) 2000-10-18
PT1315518E (pt) 2010-03-05

Similar Documents

Publication Publication Date Title
ES2181306T3 (es) Vacunas recombinantes que comprenden bacterias atenuadas inmunogenicas que tienen fenotipo rpos positivo.
NO20075727L (no) Vaksineblanding omfattende B-subenhet av et E.coli varmetoksin og et antigen og en adjuvans
ATE450270T1 (de) Impstoff gegen mikrobielle pathogenen
ATE315090T1 (de) Impfstoffherstellung des bacillus anthracis schutzantigens
ATE473236T1 (de) Antigene von piscirickettsia salmonis und deren verwendung
ES2070266T3 (es) Vacuna contra la infeccion por escherichia coli.
DE69322092D1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
ATE507286T1 (de) Immunisierung von fischen gegen virusinfektion
WO2001063278A3 (en) Antigenic fragments associated with stress-induced proteins and their use as vaccines
ATE542544T1 (de) Pro-apoptotische bakterielle impfstoffe zur verbesserung der zellulären immunantwort
CY1105947T1 (el) Νουκλεϊνικα οξεα και πρωτεϊνες του γονιδιου mhp3 του mycoplasma hyopneumoniae και χρησεις αυτων
ATE494377T1 (de) Vakzine gegen ipnv die aus hefezellen isoliert werden
WO2005012538A3 (en) Accelerated vaccination
ATE449610T1 (de) Stress-proteine extrazellulärer pathogene als impfstoffe gegen infektiöse erreger
NO20062469L (no) Streptococcus phocae vaksine
ATE353226T1 (de) Adjuvanszusammensetzung enthaltend fha oder ein fha-fragment in freier form
CA2366056A1 (en) Non-spreading pestivirus
PT1370668E (pt) Vacinas de vector baseadas em leporipox
AU1853995A (en) Vaccine compositions
ATE413887T1 (de) Stress-protein-peptidkomplexe als impfstoffe gegen intrazelluläre pathogene
WO2002067982A3 (en) Mycobacterial vaccines
AP2003002944A0 (en) Method to generate non virulent microorganisms from pathogenic ones through permanent genetic modification of their biological membrane for vaccine production.
CU23358B7 (es) Vacuna que comprende una proteína cemento de garrapata
WO2006037383A8 (en) Piscirickettsia salmonis antigens and use thereof
ATE341613T1 (de) Fluordesoxyuridin-resistente streptococcus gordonii stämme

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1315518

Country of ref document: EP